These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Proscillardin A in the treatment of cardiocirculatory insufficiency. Clinco-experimental contribution]. Bellomo A, Strobbia R, Lalloni R, Dalzotto U. Minerva Med; 1967 Dec 01; 58(96):4246-62. PubMed ID: 6083286 [No Abstract] [Full Text] [Related]
12. [Long-term study with the novel cardiac glycoside meproscillarin (author's transl)]. Eckardt A, Koch W, Safer A. Arzneimittelforschung; 1978 Dec 01; 28(3a):570-3. PubMed ID: 348206 [Abstract] [Full Text] [Related]
15. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies]. Pagliara R. Minerva Med; 1967 Dec 01; 58(96):4296-301. PubMed ID: 6081717 [No Abstract] [Full Text] [Related]
16. [Pharmacology and therapeutic effects of a new semisynthetic cardioactive glycoside (P1)]. Königstein RP, Lindner A, Selzer H. Wien Med Wochenschr; 1971 Jan 23; 121(4):53-6. PubMed ID: 5103273 [No Abstract] [Full Text] [Related]
17. [Clinical studies on the effect of Dezacetylolanatozide C (Polfa) in the treatment of heart diseases]. Wolański I, Grzywa M, Fijalkowska A. Przegl Lek; 1969 Apr 14; 25(4):377-9. PubMed ID: 4892828 [No Abstract] [Full Text] [Related]
19. [Action of oral proscillaridin treatment in various forms of heart insufficiency]. Muth HW, Weyer H. Med Welt; 1965 Dec 18; 51():2883-6. PubMed ID: 5884860 [No Abstract] [Full Text] [Related]